With 95% Efficacy, Sputnik V To Be Cheaper Than US Vaccines
Mumbai: Russia’s Sputnik V COVID-19 vaccine that has reported 95 per cent efficacy will be much cheaper than the vaccines produced by Pfizer and Moderna.
Developed by Gamaleya Institute and RDIF (Russian Direct Investment Fund), Sputnik…